BioGX is a biotechnology company that specializes in the development and manufacture of molecular diagnostics solutions. The company offers a large portfolio of CE-IVD marked tests, spread across a wide variety of infectious diseases ranging from COVID-19, respiratory to sexual health, enteric pathogens, drug resistance, meningitis, transplant and tropical disease. Their assays are designed for use on various molecular diagnostic platforms. BioGX's portfolio of assays covers a broad range of pathogens and genetic markers, providing valuable tools for accurate and timely diagnosis.
Tests for BD MAX™ Platform
BioGX have designed several tests to be used on BD MAX™ platform, including tests for respiratory and urinary tract infections, STI & Women’s Health, Meningitis and Encephalitis, and Drug Resistance.